Last reviewed · How we verify

L+E mandibular anesthesia

University of Belgrade · Phase 3 active Small molecule

L+E mandibular anesthesia is a local anesthetic formulation designed to provide regional anesthesia of the mandibular nerve for dental and oral surgical procedures.

L+E mandibular anesthesia is a local anesthetic formulation designed to provide regional anesthesia of the mandibular nerve for dental and oral surgical procedures. Used for Mandibular nerve block for dental anesthesia, Regional anesthesia for oral and maxillofacial surgery.

At a glance

Generic nameL+E mandibular anesthesia
SponsorUniversity of Belgrade
Drug classLocal anesthetic
ModalitySmall molecule
Therapeutic areaAnesthesia / Dentistry
PhasePhase 3

Mechanism of action

This formulation combines local anesthetic agents (likely lidocaine and epinephrine based on the 'L+E' designation) to block nerve conduction in the mandibular division of the trigeminal nerve, producing sensory anesthesia of the lower jaw, teeth, and associated tissues. The epinephrine component acts as a vasoconstrictor to prolong anesthetic duration and reduce systemic absorption of the local anesthetic agent.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: